The Current Ratio as of December 2025 (TTM) for Opus Genetics, Inc. (IRD) is 1.90

According to Opus Genetics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.90. This represents a change of -44.64% compared to the average of 3.44 of the last 4 quarters.

Opus Genetics, Inc. (IRD) Historical Current Ratio (quarterly & annually)

How has IRD Current Ratio performed in the past?

The mean historical Current Ratio of Opus Genetics, Inc. over the last ten years is 7.81. The current 1.90 Current Ratio has changed 2.34% with respect to the historical average. Over the past ten years (40 quarters), IRD's Current Ratio was at its highest in in the December 2022 quarter at 17.79. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Opus Genetics, Inc. (IRD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Opus Genetics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Opus Genetics, Inc. (IRD) Average Current Ratio

How has IRD Current Ratio performed in the past?

The current Current Ratio of Opus Genetics, Inc. (IRD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Opus Genetics, Inc. (IRD) Current Ratio vs. Peers

How is IRD’s Current Ratio compared to its peers?

Opus Genetics, Inc.’s Current Ratio is less than Acumen Pharmaceuticals, Inc. (6.02), less than Seer, Inc. (14.25), greater than Agenus Inc. (0.06), greater than Inovio Pharmaceuticals, Inc. (1.66), less than VistaGen Therapeutics, Inc. (5.79), greater than TuHURA Biosciences, Inc. (0.83), less than Alector, Inc. (3.76), greater than Cognition Therapeutics, Inc. (1.54), less than Instil Bio, Inc. (14.97), less than Seres Therapeutics, Inc. (2.30),

Build a custom stock screener for Opus Genetics, Inc. (IRD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opus Genetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opus Genetics, Inc. (IRD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opus Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.